This is a $18,897.85 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OPZELURA 1.5% cream, a prescription medication, with a period of performance through May 19, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This is a $6,292.31 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of OPZELURA 1.5% cream. The order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This is a $3,612.00 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of OPZELURA 1.5% cream in 60g quantities. The contract has an ultimate completion date of September 11, 2024. No set-aside designation was used for this award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,502.37, is for the supply of OPZELURA 1.5% Cream, a pharmaceutical product. The contract is a firm fixed-price delivery order, with a period of performance through December 23, 2024. It is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,692.26, is for the supply of OPZELURA 1.5% Cream in 60 gram units, with a period of performance through April 10, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award, valued at $8,025.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPZELURA 1.5% Cream, a pharmaceutical product, with a completion date of February 27, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $37,226.11 firm fixed-price contract is for the delivery of OPZELURA 1.5% CREAM 60GM, a medical product, with a period of performance through January 9, 2025. The award is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OPZELURA 1.5% Cream, a pharmaceutical product, with a ceiling value of $1,310.45 and a period of performance through May 21, 2025. The contract is not set aside and was competitively awarded. Amerisourcebergen Drug Corp holds a larger...
This is a $9,971.49 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The order is for the pharmaceutical product OPZELURA 1.5% Cream in 60g containers, with a period of performance through August 12, 2024. The contract has no set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, is supplying this product under one of its Indefinite Delivery Contracts with DLA Troop Support Medical,...
This is a $19,021.72 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical, a major medical supplier to the Department of Defense. The order is for the pharmaceutical product OPZELURA 1.5% Cream 60GM. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, that allows the agency to efficiently procure a comprehensive...